lunes, 28 de agosto de 2023

CDER Small Business and Industry Assistance (SBIA) Presents Use of Biomarkers for Diagnosing and Assessing Treatment Response in Noncirrhotic NASH Trials

CDER Small Business and Industry Assistance (SBIA) Presents https://www.fda.gov/drugs/news-events-human-drugs/use-biomarkers-diagnosing-and-assessing-treatment-response-noncirrhotic-nash-trials-09182023?utm_medium=email&utm_source=govdelivery Use of Biomarkers for Diagnosing and Assessing Treatment Response in Noncirrhotic NASH Trials https://www.fda.gov/media/171426/download?attachment=&utm_medium=email&utm_source=govdelivery

No hay comentarios: